1/ OPES ISSUE: We are already taking very specific action on a number of fronts.I would like to personally assure you that any action taken by either Solagran or Solamind in this matter will be done with the interests of all shareholders in mind – be they big or small.
2/Sale of BIOEFFECTIVE@A is up 83% (Mar08 vs Dec07)
3/ Production of BioEffective@R: commercial production facility is completed in Tomsk and is now in the process of making the first commercial quantity of Bioeffective® R.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)